NEW YORK (Reuters Health) – Patients with the H1N1 virus who started oseltamivir in the first 3 days of illness had shorter periods of viral shedding, according to…
NEW YORK (Reuters Health) – As first-line treatment for progressive chronic lymphocytic leukemia (CLL), cladribine and fludarabine are equally effective and safe in combination with cyclophosphamide, according to…
NEW YORK (Reuters Health) – With small breast cancers, doing complete axillary dissections only for positive sentinel lymph node biopsies (SNLB) yields the same 10-year survival – roughly…
NEW YORK (Reuters Health) – Injection of Macroplastique (Uroplasty), a urethral bulking agent, can improve female stress urinary incontinence for at least two years, new research shows. Exactly…
NEW YORK (Reuters Health) – There’s no good evidence that maintenance therapy improves the outcome of small-cell lung cancer (SCLC), according to a meta-analysis published February 25th in…
NEW YORK (Reuters Health) – A treatment called DRIFT (Drainage, Irrigation, and Fibrinolytic Therapy) may improve developmental outcomes and survival in preterm infants with posthemorrhagic cerebral ventricular dilatation,…
NEW YORK (Reuters Health) – In patients with Barrett’s high-grade dysplasia or early esophageal adenocarcinoma, endoscopic resection improves staging and “dramatically” reduces esophagectomy rates, Australian physicians report. Esophagectomy,…
NEW YORK (Reuters Health) – Statin use by women cuts their risk of primary cardiovascular disease (CVD) events by roughly a third, which is similar to the risk…
NEW YORK (Reuters Health) – Three years after ST-segment elevation myocardial infarction (STEMI), sirolimus-eluting stents still provide better protection against major adverse cardiovascular events compared to bare metal…
NEW YORK (Reuters Health) – Patients report higher quality of life with continuous intraperitoneal versus subcutaneous insulin, Dutch investigators have found. The researchers had previously reported that continuous…
